Duopharma Biotech Berhad

Duopharma Biotech Berhad

Duopharma Biotech Berhad is a biotech-focused asset manager headquartered in Kuala Lumpur, Malaysia, with additional offices in Boca Raton, Boston, San Francisco, Cambridge, and West Palm Beach. The firm's investment strategy spans therapeutic categories including oncology, neurology, and rare diseases. Deploying via direct equity and structured financings, Duopharma Biotech Berhad participates in private placements, IPOs, and pre-commercialization rounds. Known portfolio involvement includes specialty pharmaceutical companies focused on infectious diseases and metabolic disorders. Geographically, the firm invests primarily in North American and Asian biotech markets, reflecting its dual presence in Malaysia and US biotech hubs. Total AUM and team size are not publicly disclosed. Adjacent relationships or philanthropic vehicles related to the firm are unconfirmed. A structural differentiator is Duopharma Biotech Berhad's multi-office model spanning biotech clusters in both Asia and the US, which may provide sourcing advantages in emerging-market drug development. The firm's governance structure and succession plans remain opaque, as limited public reporting is available.